These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 34125899

  • 1. Impact of Vitamin D and Calcium Supplementation on Bone Mineral Density and Bone Metabolism Among Thai Adolescents With Perinatally Acquired Human Immunodeficiency Virus (HIV) Infection: A Randomized Clinical Trial.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kanjanavanit S, Chotecharoentanan T, Sricharoen N, Ounchanum P, Suntarattiwong P, Pornpaisalsakul K, Puthanakit T, CAL-D Study Group.
    Clin Infect Dis; 2021 Nov 02; 73(9):1555-1564. PubMed ID: 34125899
    [Abstract] [Full Text] [Related]

  • 2. A Three-Year Follow-Up of Bone Density Among Thai Adolescents With Perinatally Acquired HIV After Completion of Vitamin D and Calcium Supplementation.
    Sudjaritruk T, Kanjanavanit S, Chaito T, Sricharoen N, Prasarakee C, Sarachai S, Puthanakit T.
    J Adolesc Health; 2023 Aug 02; 73(2):262-270. PubMed ID: 37294251
    [Abstract] [Full Text] [Related]

  • 3. Effects of vitamin D and calcium supplementation on bone mineral density among Thai youth using daily HIV pre-exposure prophylaxis.
    Pornpaisalsakul K, Songtaweesin WN, Tepmongkol S, Wongharn P, Kawichai S, Suponsilchai V, Anugulruengkitt S, Puthanakit T, CE-PID - IHRI Adolescent Study Team.
    J Int AIDS Soc; 2020 Oct 02; 23(10):e25624. PubMed ID: 33040465
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.
    Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Harris DR, Price G, Baker A, Meyer WA, Wilson CM, Hazra R, Kapogiannis BG, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 109 Study Team.
    Clin Infect Dis; 2018 Jan 06; 66(2):220-228. PubMed ID: 29020329
    [Abstract] [Full Text] [Related]

  • 5. Effect of calcium and vitamin D supplementation on bone mineral accrual among HIV-infected Thai adolescents with low bone mineral density.
    Puthanakit T, Wittawatmongkol O, Poomlek V, Sudjaritruk T, Brukesawan C, Bunupuradah T, Sricharoenchai S, Chuanjaroen T, Prasitsuebsai W, Chokephaibulkit K.
    J Virus Erad; 2018 Jan 01; 4(1):6-11. PubMed ID: 29568546
    [Abstract] [Full Text] [Related]

  • 6. Early renal impairment affects hormonal regulators of calcium and bone metabolism and Wnt signalling and the response to vitamin D supplementation in healthy older adults.
    Christodoulou M, Aspray TJ, Piec I, Washbourne C, Tang JCY, Fraser WD, Schoenmakers I, VDOP Trial group, Terry J Aspray, Roger M Francis, Elaine McColl, Thomas Chadwick, Ann Prentice, Inez Schoenmakers.
    J Steroid Biochem Mol Biol; 2023 May 01; 229():106267. PubMed ID: 36739953
    [Abstract] [Full Text] [Related]

  • 7. Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth.
    Eckard AR, OʼRiordan MA, Rosebush JC, Ruff JH, Chahroudi A, Labbato D, Daniels JE, Uribe-Leitz M, Tangpricha V, McComsey GA.
    J Acquir Immune Defic Syndr; 2017 Dec 15; 76(5):539-546. PubMed ID: 28902705
    [Abstract] [Full Text] [Related]

  • 8. Elevated bone turnover markers predict bone mineral density accrual in adolescents with 21-hydroxylase deficiency.
    Wiromrat P, Namphaisan P, Wongsurawat N, Panamonta O, Nasomyont N.
    Clin Endocrinol (Oxf); 2023 Nov 15; 99(5):462-469. PubMed ID: 35941818
    [Abstract] [Full Text] [Related]

  • 9. Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Ananworanich J, Puthanakit T, Bone-D Study Group.
    AIDS; 2016 Apr 24; 30(7):1059-67. PubMed ID: 26807972
    [Abstract] [Full Text] [Related]

  • 10. Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial.
    Rovner AJ, Stallings VA, Rutstein R, Schall JI, Leonard MB, Zemel BS.
    Osteoporos Int; 2017 Jan 24; 28(1):201-209. PubMed ID: 27837268
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.
    Havens PL, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Mulligan K, Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions 063 study team.
    Clin Infect Dis; 2012 Apr 24; 54(7):1013-25. PubMed ID: 22267714
    [Abstract] [Full Text] [Related]

  • 12. Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation.
    Yin MT, Chan ES, Brown TT, Tebas P, McComsey GA, Melbourne KM, Napoli A, Hardin WR, Ribaudo HJ, Overton ET, A5280 Study Team.
    AIDS; 2017 Nov 13; 31(17):2337-2344. PubMed ID: 28832406
    [Abstract] [Full Text] [Related]

  • 13. Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.
    Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, Kranzer K, Mabuda HB, Mujuru H, Redzo N, Rowland-Jones S, Schaible UE, Simms V, Ferrand RA, VITALITY team.
    Trials; 2024 Jul 22; 25(1):499. PubMed ID: 39039558
    [Abstract] [Full Text] [Related]

  • 14. Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial.
    Arpadi SM, McMahon DJ, Abrams EJ, Bamji M, Purswani M, Engelson ES, Horlick M, Shane E.
    Am J Clin Nutr; 2012 Mar 22; 95(3):678-85. PubMed ID: 22258265
    [Abstract] [Full Text] [Related]

  • 15. A Randomized Placebo-Controlled Trial of Low- Versus Moderate-Dose Vitamin D3 Supplementation on Bone Mineral Density in Postmenopausal Women With HIV.
    Yin MT, RoyChoudhury A, Bucovsky M, Colon I, Ferris DC, Olender S, Agarwal S, Sharma A, Zeana C, Zingman B, Shane E.
    J Acquir Immune Defic Syndr; 2019 Mar 01; 80(3):342-349. PubMed ID: 30531305
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.
    Evid Rep Technol Assess (Full Rep); 2007 Aug 01; (158):1-235. PubMed ID: 18088161
    [Abstract] [Full Text] [Related]

  • 17. Effects of milk powder intervention on bone mineral density and indicators related to bone metabolism in Chinese adolescents.
    Lu JX, Pan H, Hu XQ, Huang ZW, Zhang Q.
    Osteoporos Int; 2019 Nov 01; 30(11):2231-2239. PubMed ID: 31375874
    [Abstract] [Full Text] [Related]

  • 18. Safety and Efficacy of High-Dose Daily Vitamin D3 Supplementation in Children and Young Adults Infected With Human Immunodeficiency Virus.
    Dougherty KA, Schall JI, Zemel BS, Tuluc F, Hou X, Rutstein RM, Stallings VA.
    J Pediatric Infect Dis Soc; 2014 Dec 01; 3(4):294-303. PubMed ID: 26625449
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T, Saksawad R, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K.
    J Acquir Immune Defic Syndr; 2012 Dec 01; 61(4):477-83. PubMed ID: 22918157
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.
    Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, Kranzer K, Mabuda HB, Mujuru H, Redzo N, Rowland-Jones S, Schaible UE, Simms V, Ferrand RA, VITALITY team.
    Trials; 2022 Jan 26; 23(1):78. PubMed ID: 35081986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.